-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The economic impact of obesity in the United States
Review
(7743) Views (2149) Full article downloads
Authors: Ross A Hammond, Ruth Levine
Published Date August 2010
Volume 2010:3 Pages 285 - 295
DOI: http://dx.doi.org/10.2147/DMSO.S7384
Ross A Hammond, Ruth LevineEconomic Studies Program, Brookings Institution, Washington DC, USA
Abstract: Over the past several decades, obesity has grown into a major global epidemic. In the United States (US), more than two-thirds of adults are now overweight and one-third is obese. In this article, we provide an overview of the state of research on the likely economic impact of the US obesity epidemic at the national level. Research to date has identified at least four major categories of economic impact linked with the obesity epidemic: direct medical costs, productivity costs, transportation costs, and human capital costs. We review current evidence on each set of costs in turn, and identify important gaps for future research and potential trends in future economic impacts of obesity. Although more comprehensive analysis of costs is needed, substantial economic impacts of obesity are identified in all four categories by existing research. The magnitude of potential economic impact underscores the importance of the obesity epidemic as a focus for policy and a topic for future research.
Keywords: obesity, economic impact, United States, economic cost
Readers of this article also read:
Alogliptin: a new addition to the class of DPP-4 inhibitors
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Dashboards in neonatology
The western diet and lifestyle and diseases of civilization
Uncovering undetected hypoglycemic events
Obesity: considerations about etiology, metabolism, and the use of experimental models
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- The economic impact of obesity in the United States
- Alogliptin: a new addition to the class of DPP-4 inhibitors
- Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
- Adipose inflammation: cause or consequence of obesity-related insulin resistance




